Business Description
BriaCell Therapeutics Corp. is a Canadian biotechnology company focused on creating new ways to treat cancer by training the immune system to fight tumors. Its most advanced treatment, Bria-IMT, is currently in Phase 3 trials for late-stage breast cancer, while other programs target a broader range of cancers including prostate cancer. The company works with leading research institutions, including a collaboration with MSK Accelerator, to bring its therapies to patients faster.
